DarioHealth Corp. (DRIO) stock
DRIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/3099% below fair value
$1.15−0.11 (-8.73%)
Close on Nov 16, 2026Market cap $11.27MP/E 0.3Yield –
DarioHealth operating margin
Operating margin is operating income as a percentage of revenue.
DarioHealth's operating margin for the twelve months ending Jun 30, 2026 was -151.6%. For fiscal 2025 it was -163.9%, against -213.6% the year before. The highest annual figure on record is -163.9% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -163.9% | +49.6 |
| FY2024 | Dec 31, 2024 | -213.6% | +62.5 |
| FY2023 | Dec 31, 2023 | -276.1% | −70.7 |
| FY2022 | Dec 31, 2022 | -205.4% | +167.5 |
| FY2021 | Dec 31, 2021 | -372.9% | +21.8 |
| FY2020 | Dec 31, 2020 | -394.7% | −160.5 |
| FY2019 | Dec 31, 2019 | -234.2% | +5.0 |
| FY2018 | Dec 31, 2018 | -239.2% | +39.7 |
| FY2017 | Dec 31, 2017 | -278.9% | +117.1 |
| FY2016 | Dec 31, 2016 | -396.0% | +539.3 |
| FY2015 | Dec 31, 2015 | -935.4% | +21335.2 |
| FY2014 | Dec 31, 2014 | -22270.6% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -125.1% | +46.2 |
| Q1 FY2026 | Mar 31, 2026 | -130.9% | +8.5 |
| Q4 FY2025 | Dec 31, 2025 | -163.7% | −10.2 |
| Q3 FY2025 | Sep 30, 2025 | -189.4% | −27.4 |
| Q2 FY2025 | Jun 30, 2025 | -171.4% | +87.5 |
| Q1 FY2025 | Mar 31, 2025 | -139.4% | +170.7 |
| Q4 FY2024 | Dec 31, 2024 | -153.4% | +239.7 |
| Q3 FY2024 | Sep 30, 2024 | -162.1% | +279.8 |
| Q2 FY2024 | Jun 30, 2024 | -258.8% | −31.0 |
| Q1 FY2024 | Mar 31, 2024 | -310.1% | −134.5 |
| Q4 FY2023 | Dec 31, 2023 | -393.1% | −260.8 |
| Q3 FY2023 | Sep 30, 2023 | -441.9% | −221.3 |
| Q2 FY2023 | Jun 30, 2023 | -227.9% | +52.8 |
| Q1 FY2023 | Mar 31, 2023 | -175.6% | +21.3 |
| Q4 FY2022 | Dec 31, 2022 | -132.3% | +227.1 |
| Q3 FY2022 | Sep 30, 2022 | -220.6% | +179.1 |
| Q2 FY2022 | Jun 30, 2022 | -280.7% | +61.5 |
| Q1 FY2022 | Mar 31, 2022 | -196.9% | +201.6 |
| Q4 FY2021 | Dec 31, 2021 | -359.4% | +76.4 |
| Q3 FY2021 | Sep 30, 2021 | -399.7% | −76.4 |
| Q2 FY2021 | Jun 30, 2021 | -342.2% | −111.5 |
| Q1 FY2021 | Mar 31, 2021 | -398.5% | +208.2 |
| Q4 FY2020 | Dec 31, 2020 | -435.8% | −203.2 |
| Q3 FY2020 | Sep 30, 2020 | -323.3% | −173.5 |
| Q2 FY2020 | Jun 30, 2020 | -230.7% | +94.1 |
| Q1 FY2020 | Mar 31, 2020 | -606.7% | −367.5 |
| Q4 FY2019 | Dec 31, 2019 | -232.5% | +57.2 |
| Q3 FY2019 | Sep 30, 2019 | -149.8% | +65.9 |
| Q2 FY2019 | Jun 30, 2019 | -324.8% | −43.4 |
| Q1 FY2019 | Mar 31, 2019 | -239.2% | −73.2 |
| Q4 FY2018 | Dec 31, 2018 | -289.8% | −92.2 |
| Q3 FY2018 | Sep 30, 2018 | -215.8% | +0.9 |
| Q2 FY2018 | Jun 30, 2018 | -281.4% | +59.0 |
| Q1 FY2018 | Mar 31, 2018 | -166.0% | +251.6 |
| Q4 FY2017 | Dec 31, 2017 | -197.5% | +260.0 |
| Q3 FY2017 | Sep 30, 2017 | -216.7% | +157.1 |
| Q2 FY2017 | Jun 30, 2017 | -340.3% | – |
| Q1 FY2017 | Mar 31, 2017 | -417.6% | – |
| Q4 FY2016 | Dec 31, 2016 | -457.5% | – |
| Q3 FY2016 | Sep 30, 2016 | -373.8% | – |
See a number that looks wrong?